Pharmaceutical compositions containing enterokine-releasing substances in multiple dosage forms in combination with gelling agents

KE8267BUndetermined Publication Date: 2026-06-19APHAIA PHARMA AG
0 Cites 0 Cited by

Patent Information

Application Number
KE2023014627
Authority / Receiving Office
KE · KE
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-06-10
Publication Date
2026-06-19
Estimated Expiration
2040-06-10
Patent Text Reader

Abstract

The present invention relates to pharmaceutical compositions and pharmaceutical articles comprising such compositions wherein the compositions comprise multiple dosage forms each comprising a core and an enteric coating, wherein the core comprises at least one compound stimulating enteroendocrine cells to release at least one enterokine, wherein the size of the dosage forms, with respect to the largest dimension of the dosage forms, provides for entry of the dosage forms into the intestine of a subject independent of gastric emptying mechanisms, and wherein the composition further comprises one or more gelling agents. The invention also relates to the treatment and / or prevention of conditions amenable to stimulation of enterokine release by enteroendocrine cells.
Need to check novelty before this filing date? Find Prior Art